Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein

The tumor suppressor gene DLC1 can be downregulated in cancers through genetic and non-genetic mechanisms. Here, the authors show cytoplasmic EZH2 can directly methylate and destabilize the DLC1 protein, and EZH2 inhibition can increase the DLC1 protein half-life at least 20-fold.

Guardado en:
Detalles Bibliográficos
Autores principales: Brajendra K. Tripathi, Meghan F. Anderman, Disha Bhargava, Luciarita Boccuzzi, Xiaolan Qian, Dunrui Wang, Marian E. Durkin, Alex G. Papageorge, Fernando J. de Miguel, Katerina Politi, Kylie J. Walters, James H. Doroshow, Douglas R. Lowy
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/7176f11d2bb2458e8f04d65843a147be
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7176f11d2bb2458e8f04d65843a147be
record_format dspace
spelling oai:doaj.org-article:7176f11d2bb2458e8f04d65843a147be2021-12-05T12:22:07ZInhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein10.1038/s41467-021-26993-32041-1723https://doaj.org/article/7176f11d2bb2458e8f04d65843a147be2021-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-26993-3https://doaj.org/toc/2041-1723The tumor suppressor gene DLC1 can be downregulated in cancers through genetic and non-genetic mechanisms. Here, the authors show cytoplasmic EZH2 can directly methylate and destabilize the DLC1 protein, and EZH2 inhibition can increase the DLC1 protein half-life at least 20-fold.Brajendra K. TripathiMeghan F. AndermanDisha BhargavaLuciarita BoccuzziXiaolan QianDunrui WangMarian E. DurkinAlex G. PapageorgeFernando J. de MiguelKaterina PolitiKylie J. WaltersJames H. DoroshowDouglas R. LowyNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Brajendra K. Tripathi
Meghan F. Anderman
Disha Bhargava
Luciarita Boccuzzi
Xiaolan Qian
Dunrui Wang
Marian E. Durkin
Alex G. Papageorge
Fernando J. de Miguel
Katerina Politi
Kylie J. Walters
James H. Doroshow
Douglas R. Lowy
Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
description The tumor suppressor gene DLC1 can be downregulated in cancers through genetic and non-genetic mechanisms. Here, the authors show cytoplasmic EZH2 can directly methylate and destabilize the DLC1 protein, and EZH2 inhibition can increase the DLC1 protein half-life at least 20-fold.
format article
author Brajendra K. Tripathi
Meghan F. Anderman
Disha Bhargava
Luciarita Boccuzzi
Xiaolan Qian
Dunrui Wang
Marian E. Durkin
Alex G. Papageorge
Fernando J. de Miguel
Katerina Politi
Kylie J. Walters
James H. Doroshow
Douglas R. Lowy
author_facet Brajendra K. Tripathi
Meghan F. Anderman
Disha Bhargava
Luciarita Boccuzzi
Xiaolan Qian
Dunrui Wang
Marian E. Durkin
Alex G. Papageorge
Fernando J. de Miguel
Katerina Politi
Kylie J. Walters
James H. Doroshow
Douglas R. Lowy
author_sort Brajendra K. Tripathi
title Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
title_short Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
title_full Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
title_fullStr Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
title_full_unstemmed Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
title_sort inhibition of cytoplasmic ezh2 induces antitumor activity through stabilization of the dlc1 tumor suppressor protein
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/7176f11d2bb2458e8f04d65843a147be
work_keys_str_mv AT brajendraktripathi inhibitionofcytoplasmicezh2inducesantitumoractivitythroughstabilizationofthedlc1tumorsuppressorprotein
AT meghanfanderman inhibitionofcytoplasmicezh2inducesantitumoractivitythroughstabilizationofthedlc1tumorsuppressorprotein
AT dishabhargava inhibitionofcytoplasmicezh2inducesantitumoractivitythroughstabilizationofthedlc1tumorsuppressorprotein
AT luciaritaboccuzzi inhibitionofcytoplasmicezh2inducesantitumoractivitythroughstabilizationofthedlc1tumorsuppressorprotein
AT xiaolanqian inhibitionofcytoplasmicezh2inducesantitumoractivitythroughstabilizationofthedlc1tumorsuppressorprotein
AT dunruiwang inhibitionofcytoplasmicezh2inducesantitumoractivitythroughstabilizationofthedlc1tumorsuppressorprotein
AT marianedurkin inhibitionofcytoplasmicezh2inducesantitumoractivitythroughstabilizationofthedlc1tumorsuppressorprotein
AT alexgpapageorge inhibitionofcytoplasmicezh2inducesantitumoractivitythroughstabilizationofthedlc1tumorsuppressorprotein
AT fernandojdemiguel inhibitionofcytoplasmicezh2inducesantitumoractivitythroughstabilizationofthedlc1tumorsuppressorprotein
AT katerinapoliti inhibitionofcytoplasmicezh2inducesantitumoractivitythroughstabilizationofthedlc1tumorsuppressorprotein
AT kyliejwalters inhibitionofcytoplasmicezh2inducesantitumoractivitythroughstabilizationofthedlc1tumorsuppressorprotein
AT jameshdoroshow inhibitionofcytoplasmicezh2inducesantitumoractivitythroughstabilizationofthedlc1tumorsuppressorprotein
AT douglasrlowy inhibitionofcytoplasmicezh2inducesantitumoractivitythroughstabilizationofthedlc1tumorsuppressorprotein
_version_ 1718372023209558016